Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma

Trial number:
Trial phase:
Study type:
Local/Regional therapies, Chemotherapy
Overall status:

Study start date

December, 2023

Scientific title

A Randomized Phase III Study of Adjuvant Radiotherapy Versus Adjuvant Radiochemotherapy in Patients With Incomplete ResectionThymoma or Thymic Carcinoma


This study is designed to investigate whether adjuvant radiochemotherapy after incomplete resection has a better survival than adjuvant radiotherapy for thymoma or thymic carcinoma.

18~75 years old; Eastern Cooperative Oncology Group performance status of 0 to 2; Pathologically confirmed ; incomplete resection (R1 or R2);have adequate bone marrow, hepatic, and renal function;Patients receive incomplete resection within 3 months; Written informed consent.

Study design

Primary purpose: Treatment, Allocation: Randomized, Intervention model: Parallel Assignment, Masking: None (Open Label),


Thymoma and Thymic Carcinoma

Other study ID numbers


Choose trial site (1)